PHC's Pivotal Research Initiates Largest Phase I Alzheimer's Disease Trial To Date For Major National Sponsor

Main Category: Alzheimer's / Dementia
Also Included In: Clinical Trials / Drug Trials
Article Date: 14 Apr 2008 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

PHC, Inc. (AMEX: PHC) d.b.a. Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services and pharmaceutical research, reported that its Pivotal Research Centers has initiated its largest Phase I Alzheimer's Disease trial to date for a major national sponsor.

In collaboration with four prestigious neurologists, Pivotal has begun screening patients for the Phase I research effort, which is expected to have major implications for the treatment of Alzheimer patients. The first patient is expected in-house early April 2008. The Phase I activity will continue through July 2008.

The study will involve 21 randomized patients who, under close protocol, will reside in Pivotal's Phase I unit for the duration of 28 days. Pivotal Research Centers will utilize its trained and experienced Phase I staff to provide the expertise required for the compliance and success of the trial.

Management anticipates this to be the first of many large scale, in-patient, early-phase research studies to come. "This is the first big study since we opened our new Phase I expanded 15-bed unit this fiscal year," said Bruce A. Shear, Pioneer's president and CEO. "We anticipate this study to generate approximately $750,000 over the next four months and boost profits in the current quarter."

About Pivotal Research Centers

Pivotal Research Centers is one of the largest and most successful clinical research organizations in the nation. Having successfully completed over 600 research studies in over 45 indications, Pivotal's sites are consistently top-enrolling in numerous studies and consistently delivers high-quality, clean data. It has extensive experience in multiple therapeutic areas with a focus in neurological, psychiatric, women's health,oncology and selected internal medicine indications. Pivotal, with it's unparalleled clinical expertise, thorough regulatory department, state-of-the-art management processes and comprehensive recruitment practices consistently deliver clean, reliable data and rapid patient enrollment. It's dedication and commitment to medical research has led Pivotal to be a part of 64 medications currently FDA approved and on the market. For more information, go to http://www.pivotalresearch.com.

About Pioneer Behavioral Health

Pioneer Behavioral Health operates companies that provide inpatient and outpatient behavioral health care services, clinical research and Internet and telephonic-based referral services. The companies contract with national insurance companies, government payors, and major transportation and gaming companies, among others, to provide such services.

Pioneer Behavioral Health